| Name
|
Adrenomedullin (1-52), human
|
| Code
|
[148498-78-6]
|
| The alias
|
Adrenomedullin (1-52), human
|
| Sequence (single letter abbreviation)
|
YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2?(Cys16 and 21 bridge)
|
| Sequence (three-letter abbreviation)
|
H-Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2?(trifluoroacetate salt)(Cys16 and 21 bridge)
|
| A basic description
|
Possessor of vasodilatory activity and proposed modulator of receptor-mediated pulmonary vascular contraction by influence of Ca2+ influx. This fragment has also been suggested to be an endothelium-dependent vasodilator agent in pulmonary vascular bed in rats and a vascular phase modulator in inflammation
|
| solubility
|
|
| The molecular weight
|
6028.9
|
| Chemical formula
|
C264H406N80O77S3
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
K. Kitamura et al., BBRC, 192, 533 (1993)
C. Nuki et al., BBRC, 196, 245 (1993)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
(Cys16 and 21 bridge)
|